ZEAL — Zealand Pharma A/S Share News
0.000.00%
Last trade - 00:00- DKK20.13bn
- DKK6.08bn
- DKK9.21bn
Europe Research Roundup: Craneware, Croda, Genus
Novo Nordisk rises after Wegovy data
Brief: Zealand Pharma Keeps FY Guidance Unchanged
Novo continues rally on Lilly's disappointing drug data
Danish drugmakers jump as Eli Lilly's weight-loss pill data disappoints (updated)
Novo Nordisk, Zealand Pharma jump after Eli Lilly weight-loss data
Novo Nordisk shares drop 20% on profit warning, new CEO appointment
European pharmaceuticals fall on looming U.S. tariffs
Top of the Street: Handelsbanken, Arkema, Zealand Pharma, SOBI, Argenx
DB expects EU pharma 'malaise' to continue amid US headwinds
Barclays starts Zealand Pharma at 'overweight' on long-term scope for growth
BNPP starts Zealand Pharma at 'outperform' on 'difficult to ignore' obesity drugs upside
Brief: Zealand Pharma Announces Positive Results From 28-Week Phase 1B Dapiglutide Trial
Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial
Next-generation obesity drugs in focus at upcoming diabetes meeting, Berenberg says
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial
Brief: Zealand Pharma Applies To EMA For Marketing Authorization For Glepaglutide In Short Bowel Syndrome
Europe Research Roundup: Assa Abloy, Burberry, IMI
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up